Cutler Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,400
| Closed | -$1K | – | 1714 |
|
|
2022
Q3 | $1K | Buy |
3,400
+3,200
| +1,600% | +$941 | ﹤0.01% | 1780 |
|
|
2022
Q2 | $0 | Buy |
+200
| New | – | ﹤0.01% | 1862 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1935 |
|
|
2021
Q4 | – | Sell |
-700
| Closed | -$2K | – | 2029 |
|
|
2021
Q3 | $2K | Hold |
700
| – | – | ﹤0.01% | 1951 |
|
|
2021
Q2 | $2K | Hold |
700
| – | – | ﹤0.01% | 1947 |
|
|
2021
Q1 | $2K | Hold |
700
| – | – | ﹤0.01% | 1866 |
|
|
2020
Q4 | $1K | Buy |
+700
| New | +$1K | ﹤0.01% | 1683 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1667 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1634 |
|
|
2018
Q1 | – | Sell |
-629
| Closed | -$9K | – | 1761 |
|
|
2017
Q4 | $9K | Sell |
629
-18,041
| -97% | -$258K | ﹤0.01% | 1636 |
|
|
2017
Q3 | $367K | Buy |
18,670
+3,594
| +24% | +$70.6K | 0.01% | 542 |
|
|
2017
Q2 | $216K | Sell |
15,076
-10,982
| -42% | -$157K | 0.01% | 825 |
|
|
2017
Q1 | $239K | Buy |
26,058
+15,502
| +147% | +$142K | 0.01% | 746 |
|
|
2016
Q4 | $109K | Sell |
10,556
-5,726
| -35% | -$59.1K | ﹤0.01% | 1151 |
|
|
2016
Q3 | $147K | Sell |
16,282
-9,027
| -36% | -$81.5K | 0.01% | 915 |
|
|
2016
Q2 | $189K | Buy |
25,309
+300
| +1% | +$2.24K | 0.01% | 705 |
|
|
2016
Q1 | $225K | Buy |
25,009
+15,109
| +153% | +$136K | 0.01% | 562 |
|
|
2015
Q4 | $127K | Buy |
+9,900
| New | +$127K | 0.01% | 920 |
|